(Q54551322)

31 May 2018

title

Altered REDD1, myostatin, and Akt/mTOR/FoxO/MAPK signaling in streptozotocin-induced diabetic muscle atrophy. (English)

1 reference

31 May 2018

author

Juha J Hulmi

1

1 reference

31 May 2018

Mika Silvennoinen

2

1 reference

31 May 2018

Maarit Lehti

3

1 reference

31 May 2018

Riikka Kivelä

4

1 reference

31 May 2018

Heikki Kainulainen

5

1 reference

31 May 2018

publication date

8 November 2011

1 reference

31 May 2018

American Journal of Physiology - Endocrinology and Metabolism

published in

1 reference

31 May 2018

volume

302

1 reference

31 May 2018

issue

3

1 reference

31 May 2018

page(s)

E307-15

1 reference

31 May 2018

Oxidative stress impairs skeletal muscle repair in diabetic rats.

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Cell cycle and death control: long live Forkheads

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Tissue- and fibre-specific modifications of insulin-signalling molecules in cardiac and skeletal muscle of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Downregulation of Akt/mammalian target of rapamycin pathway in skeletal muscle is associated with increased REDD1 expression in response to chronic hypoxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Regulation of REDD1 by insulin-like growth factor-I in skeletal muscle and myotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Oxidative damage to DNA and lipids: correlation with protein glycation in patients with type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Impaired growth and force production in skeletal muscles of young partially pancreatectomized rats: a model of adolescent type 1 diabetic myopathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

New roles for the LKB1-->AMPK pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Resistance exercise with whey protein ingestion affects mTOR signaling pathway and myostatin in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Role of ghrelin in streptozotocin-induced diabetic hyperphagia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Streptozotocin induces G2 arrest in skeletal muscle myoblasts and impairs muscle growth in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Diabetic myopathy differs between Ins2Akita+/- and streptozotocin-induced Type 1 diabetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Effects of streptozotocin-induced diabetes and physical training on gene expression of extracellular matrix proteins in mouse skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Reversal of type 1 diabetes by engineering a glucose sensor in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Elevated corticosterone associated with food deprivation upregulates expression in rat skeletal muscle of the mTORC1 repressor, REDD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Signalling to translation: how signal transduction pathways control the protein synthetic machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

A role for 14-3-3 in insulin-stimulated GLUT4 translocation through its interaction with the RabGAP AS160.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Insulin induces REDD1 expression through hypoxia-inducible factor 1 activation in adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Lower skeletal muscle mass in male transgenic mice with muscle-specific overexpression of myostatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Physical activity, sport, and pediatric diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Counteraction of type 1 diabetic alterations by engineering skeletal muscle to produce insulin: insights from transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Corticosterone Regulation of Insulin-Like Growth Factor I, IGF-Binding Proteins, and Growth in Streptozotocin-Induced Diabetic Rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Identification of a novel hypoxia-inducible factor 1-responsive gene, RTP801, involved in apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Regulation of mTOR and cell growth in response to energy stress by REDD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

Relation between extent of myostatin depletion and muscle growth in mature mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

ATF4 is necessary and sufficient for ER stress-induced upregulation of REDD1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

AMPK inhibits myoblast differentiation through a PGC-1alpha-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00398.2011

10.1152/AJPENDO.00398.2011

21 January 2018

Identifiers

DOI

1 reference

31 May 2018

PubMed ID

22068602

1 reference

31 May 2018